The American Journal of Emergency Medicine 2013-11-01

Citalopram and levosulpiride: a dangerous drug combination for QT prolongation.

Sergio Agosti, Laura Casalino, Giovanni Bertero, Alessandro Burrone, Claudio Brunelli, Silvana Morelloni

Index: Am. J. Emerg. Med. 31(11) , 1624.e1-2, (2013)

Full Text: HTML

Abstract

We report the case of an 89-year-old female patient who presented to the emergency department after out-of-hospital cardiac arrest due to polymorphic ventricular tachycardia treated by public access defibrillation. The admission electrocardiogram (ECG) showed extreme QT prolongation (650 milliseconds) with recurrent episodes of nonsustained polymorphic ventricular tachycardia. Intravenous magnesium sulfate therapy was instituted. After history taking, it was found that the patient was on citalopram and that, 2 days prior to admission, she had begun treatment with levosulpiride. This drug combination resulted in marked prolongation of the QT interval that triggered the electrical storm.

Related Compounds

  • Levosulpiride
  • Sulpiride

Related Articles:

Chemical genetics reveals a complex functional ground state of neural stem cells.

2007-05-01

[Nat. Chem. Biol. 3(5) , 268-273, (2007)]

The use of dried blood spots for quantification of 15 antipsychotics and 7 metabolites with ultra-high performance liquid chromatography - tandem mass spectrometry.

2015-06-01

[Drug Test. Anal. 7 , 502-11, (2015)]

5-HT2A receptor activation is necessary for CO2-induced arousal.

2015-07-01

[J. Neurophysiol. 114 , 233-43, (2015)]

Liquid chromatography-tandem mass spectrometry quantification of levosulpiride in human plasma and its application to bioequivalence study.

2010-08-15

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 878(24) , 2280-5, (2010)]

Influence of ABCB1 genetic polymorphisms on the pharmacokinetics of levosulpiride in healthy subjects.

2010-08-11

[Neuroscience 169(1) , 378-87, (2010)]

More Articles...